Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
EJB-Egyptian Journal of Biochemistry and Molecular Biology [The]. 2009; 27 (1): 163-176
in English | IMEMR | ID: emr-91054

ABSTRACT

Chromium III tris [picolinate] [Cr[pie][3]ps a popular nutritional supplement; however its safety has been questioned, especially with regard to its ability to act as a clastogen. The aim of the preset work was to evaluate the biochemical and moiph01gicd changes in the liver following oral administration of Cr-picolinate and the possible protective effect of ascorbic acid [vitamin C] in rats. Fifty male Sprague Dawly rats were divided into five groups included the control group, the rest four groups treated orally with picolinte [0.8 and 1.5 mg 7100 g b. w] alone or in combination with Vitamin C [0.5 mg 7100 g b. w] for 8 weeks. The results indicated that animals treated with Cr-picolinate alone at the high dose level [1.5 mg/100 g b.w] showed a significant decrease in reduced glutathione [GSH] level and activity of glutathione peroxidase [GPx] in liver homogenate or blood accompanied with a significant increase in serum sFas; 8-hydroxy-2 -deoxyguanosine and malondialdehyde [MDA] levels.The hepatocytes showed some degenerative changes in the form of swollen cells and degenerating nuclei, yet some cells showed regeneration by division of their nuclei The methyl green pyronin [MGP] stain showed less level of DNA in the nuclei, the cells appeared swollen and fused in some areas. It could be concluded that consumption of Cr-picolinate for a long time is contributing to health hazards and induced several hazards to liver. Supplementation with extra amounts of vitamin C may be useful to restrain the chromium-induced biochemical and morphological changes to the liver. It is believed that oxidative stress due to Cr- picolinate is a factor contributing to this health hazards


Subject(s)
Animals, Laboratory , Animals , Liver/pathology , Histology , Oxidative Stress , Glutathione Peroxidase/blood , Malondialdehyde/blood , Protective Agents , Ascorbic Acid , Picolines/blood , Treatment Outcome , Rats
2.
Cancer Research and Treatment ; : 298-302, 2004.
Article in English | WPRIM | ID: wpr-226066

ABSTRACT

PURPOSE: The human CD24 antigen is a small heavily glycosylated cell surface protein, which is expressed in hematological malignancies, as well as in a large variety of solid tumors. Its expression is now known to be related to the prognosis of several kinds of tumors. This study is designed to examine the prognostic significance of CD24 in Korean gastric cancer patients. MATERIALS AND METHODS: In the present study, we examined CD24 expression in 300 consecutive cases of gastric carcinoma by immunohistochemical staining using the tissue-array method. We also investigated the clinicopathological profiles related to CD24 expression. RESULTS: One hundred and three cases out of 300 (34.3%) showed the positive expression of CD24. The altered expression of CD24 was significantly associated with differentiated cancer (p=0.003), the intestinal subtype according to the Lauren classification (p<0.001), the advanced stage cancer (p=0.027), with lymphatic invasion (p=0.038) and with vascular invasion (p=0.006). The survival analysis revealed that the patients with CD24 positive expression showed significantly poorer survival than those without CD24 expression. Moreover, a combined evaluation revealed that PTEN /CD24 cases showed the best survival compared to other groups (p=0.01). CONCLUSION: Positive CD24 expression occurs in a subset of gastric carcinomas and it correlates significantly with lymphatic invasion, blood vessel invasion and poor survival.


Subject(s)
Humans , CD24 Antigen , Blood Vessels , Classification , Hematologic Neoplasms , Immunohistochemistry , Prognosis , Stomach Neoplasms , Survival Analysis
SELECTION OF CITATIONS
SEARCH DETAIL